Vanderbilt is home to several other research and clinical programs that provide stem cell resources and information to patients and the community. We invite you to visit the following websites for more information on each program.
The Pediatric Stem Cell Transplant Program at Vanderbilt Children's Hospital provides comprehensive transplantation services for children with both malignant and non-malignant disorders, including metabolic disorders, hematologic disorders (sickle cell disease and thalassemia) and immune deficiencies. They have active protocols using marrow, peripheral blood stem cells, and cord blood transplants, and are an active participant in the National Marrow Donor Program (NMDP) and the Pediatric Blood & Marrow Transplant Consortium (PBMTC).
The Stem Cell Transplant Program at Vanderbilt University Medical Center provides stem cell transplantation services to treat acute and chronic leukemias, Hodgkin’s disease and non-Hodgkin’s lymphoma, multiple myeloma, myelodysplasia and aplastic anemia. The program has earned national recognition for its description of clinicopathological entities, the development of dose intensive therapy, its participation in cooperative group trials and the evaluation of the role of transplantation in these diseases.
The Vanderbilt-Ingram Cancer Center (VICC) Cancer Information Program provides information on the diagnosis, treatment and prevention of cancer. They also provide patient referrals to clinical trials (including those involving stem cell transplantation) currently being conducted at the VICC. Patients, families and referring physicians can call the toll free information hotline at 1-800-4-CANCER (1-800-811-8480).